Several research groups reported that CXCL1 [9, 10] and CXCR2 [11, 12] were poor prognostic factors in studies using human samples of several types of cancers including gastric cancer, colorectal cancer, and pancreatic cancer. This evidence concerns the gene CXCL1 and pancreatic neoplasm.